This was in concordance with a real-time PCR data, illustrating an increase of mRNA FGF-2 in IM-resistant GISTs after IM exposure, whereas IM treatment of IM-naive GIST T-1 cells substantially reduced mRNA FGF-2 levels (Figure 1F). This evidence concerns the gene FGF2 and gastrointestinal stromal tumor.